212 related articles for article (PubMed ID: 30148069)
1. Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer.
Tecalco-Cruz AC; Ramírez-Jarquín JO
World J Clin Oncol; 2018 Aug; 9(4):60-70. PubMed ID: 30148069
[TBL] [Abstract][Full Text] [Related]
2. Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells.
Tecalco-Cruz AC; Ramírez-Jarquín JO; Cruz-Ramos E
Curr Drug Targets; 2019; 20(6):690-704. PubMed ID: 30324876
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression.
Yuan L; Li X; Yang H; Li H
Hum Cell; 2023 Jan; 36(1):353-365. PubMed ID: 36271315
[TBL] [Abstract][Full Text] [Related]
4. Derailed estrogen signaling and breast cancer: an authentic couple.
Manavathi B; Dey O; Gajulapalli VN; Bhatia RS; Bugide S; Kumar R
Endocr Rev; 2013 Feb; 34(1):1-32. PubMed ID: 22947396
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor α.
Iizuka M; Susa T; Tamamori-Adachi M; Okinaga H; Okazaki T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):498-510. PubMed ID: 28769019
[TBL] [Abstract][Full Text] [Related]
6. Role of estrogen receptor coregulators in endocrine resistant breast cancer.
Altwegg KA; Vadlamudi RK
Explor Target Antitumor Ther; 2021; 2(4):385-400. PubMed ID: 34528025
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor SAHA induces ERalpha degradation in breast cancer MCF-7 cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling.
Yi X; Wei W; Wang SY; Du ZY; Xu YJ; Yu XD
Biochem Pharmacol; 2008 May; 75(9):1697-705. PubMed ID: 18342836
[TBL] [Abstract][Full Text] [Related]
8. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
9. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
10. Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer.
Tecalco-Cruz AC; Macías-Silva M; Ramírez-Jarquín JO; Ramírez-Jarquín UN
Front Endocrinol (Lausanne); 2022; 13():867448. PubMed ID: 35498431
[TBL] [Abstract][Full Text] [Related]
11. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
Fan M; Park A; Nephew KP
Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
[TBL] [Abstract][Full Text] [Related]
12. Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader.
Zhao Y; Zhao C; Lu J; Wu J; Li C; Hu Z; Tian W; Yang L; Xiang J; Zhou H; Deng Z; Huang J; Hong K
Pharmacol Res; 2019 Aug; 146():104294. PubMed ID: 31175940
[TBL] [Abstract][Full Text] [Related]
13. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1.
Ding J; Kuang P
Front Oncol; 2021; 11():664689. PubMed ID: 34094957
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary.
Alarid ET; Preisler-Mashek MT; Solodin NM
Endocrinology; 2003 Aug; 144(8):3469-76. PubMed ID: 12865327
[TBL] [Abstract][Full Text] [Related]
19. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
